Article Details
Retrieved on: 2021-03-18 00:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... and other companies including Ming Bioventures under which WuXi Bio will acquire over 90% interest of CMAB Biopharma Group ("CMAB").
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here